sorafenib has been researched along with t-tucb in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (t-tucb) | Trials (t-tucb) | Recent Studies (post-2010) (t-tucb) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 13 | 0 | 7 |
| Protein | Taxonomy | sorafenib (IC50) | t-tucb (IC50) |
|---|---|---|---|
| Fatty-acid amide hydrolase 1 | Homo sapiens (human) | 1.0667 | |
| Bifunctional epoxide hydrolase 2 | Homo sapiens (human) | 0.0009 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, SH; Hammock, BD; Hwang, SH; Morisseau, C; Nguyen, LV; Wecksler, AT; Zhang, G | 1 |
1 other study(ies) available for sorafenib and t-tucb
| Article | Year |
|---|---|
Synthesis and biological evaluation of sorafenib- and regorafenib-like sEH inhibitors.
Topics: Cell Proliferation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epoxide Hydrolases; Human Umbilical Vein Endothelial Cells; Humans; Molecular Structure; Niacinamide; Phenylurea Compounds; Pyridines; Solubility; Sorafenib; Structure-Activity Relationship | 2013 |